Market Place
Sourcing Support
Novo Nordisk`s Biologic Alhemo Receives Approval in US
20 Dec 2024 //
FDA
Alembic`s Generics Divalproex Sodium Receives Approval in US
19 Dec 2024 //
FDA
Amgen`s Biologic Kanjinti Receives Suppl Approval in US
19 Dec 2024 //
FDA
Hikma`s Generics Phytonadione Receives Approval in US
19 Dec 2024 //
FDA
Genzyme`s Biologic Cerezyme Receives Suppl Approval in US
19 Dec 2024 //
FDA
Celltrion`s Biologic Stqeyma Receives Suppl Approval in US
17 Dec 2024 //
FDA
Granules`s Generics Lisdexamfetamine Receives Approval in US
16 Dec 2024 //
FDA
MSN Lab`s Generics Perampanel Receives Tentative Approval in US
16 Dec 2024 //
FDA
Galderma`s Biologic Nemluvio Receives Approval in US
13 Dec 2024 //
FDA
Mylan`s Generics Glucagon Receives Approval in US
12 Dec 2024 //
FDA
Merck`s Biologic Keytruda Receives Suppl Approval in US
11 Dec 2024 //
FDA
Gland Pharma`s Generics Phytonadione Receives Approval in US
10 Dec 2024 //
FDA
Thinq Pharma`s Generics Chlorpromazine HCl Receives Approval in US
10 Dec 2024 //
FDA
Cipla`s Generics Eliglustat Tartrate Receives Approval in US
10 Dec 2024 //
FDA
Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US
10 Dec 2024 //
FDA
Myerus`s Biologic Bizengri Receives Approval in US
04 Dec 2024 //
FDA
AstraZeneca`s Biologic Imfinzi Receives Suppl Approval in US
04 Dec 2024 //
FDA
Amneal`s Generics Doxycycline Hyclate Receives Approval in US
04 Dec 2024 //
FDA
Astellas Pharma`s Veozah Receives Approval in Canada
03 Dec 2024 //
HEALTH CANADA
SIFI SpA`s Akantior Receives Approval in Europe
29 Nov 2024 //
EMA
Mylan Pharma`s Biologic Semglee Receives Suppl Approval in US
25 Nov 2024 //
FDA
Macleods`s Generics Apremilast Receives Approval in US
25 Nov 2024 //
FDA
Hibrow`s Generics Hydrocortisone Receives Approval in US
25 Nov 2024 //
FDA
Janseen`s Biologic Tecvayli Receives Suppl Approval in US
22 Nov 2024 //
FDA
Genentech`s Biologic Lunsumio Receives Suppl Approval in US
22 Nov 2024 //
FDA
Jazz Pharma`s Biologic Ziihera Receives Approval in US
20 Nov 2024 //
FDA
Qilu Pharma`s Generics Icosapent Ethyl Receives Approval in US
20 Nov 2024 //
FDA
Mylan`s Generics Sugammadex Receives Tentative Approval in US
20 Nov 2024 //
FDA
Amgen`s Biologic Repatha Receives Suppl Approval in US
20 Nov 2024 //
FDA
Merck Sharp`s Biologic Keytruda Receives Suppl Approval in US
20 Nov 2024 //
FDA
Regeneron`s Ordspono Receives Approval in Europe
19 Nov 2024 //
EMA
Aspiro Pharma`s Generics Chlorpromazine HCl Receives Approval in US
18 Nov 2024 //
FDA
Samsung Bioepis`s Biologic Epysqli Receives Suppl Approval in US
15 Nov 2024 //
FDA
Eisai`s Biologic Leqembi Receives Suppl Approval in US
14 Nov 2024 //
FDA
Celltrion`s Biologic Herzuma Receives Suppl Approval in US
14 Nov 2024 //
FDA
Mylan Gmbh`s Biologic Ogivri Receives Suppl Approval in US
13 Nov 2024 //
FDA
Cosette Pharma`s Generics Sucralfate Receives Approval in US
13 Nov 2024 //
FDA
Macleods`s Generics Fenofibrate Receives Approval in US
12 Nov 2024 //
FDA
Teva Pharma`s Generics Fedratinib Receives Tentative Approval in US
07 Nov 2024 //
FDA
Apotex`s Generics Rivaroxaban HCl Receives Approval in US
07 Nov 2024 //
FDA
Aspiro Pharma`s Generics Thiamine HCl Receives Approval in US
06 Nov 2024 //
FDA
Micro Labs`s Generics Metolazone Receives Approval in US
06 Nov 2024 //
FDA
IdentiRx`s Generics Ciprofloxacin HCl Receives Approval in US
05 Nov 2024 //
FDA
Upsher Smith`s Generics Deflazacort Receives Approval in US
05 Nov 2024 //
FDA
Xiamen`s Generics Topiramate Receives Approval in US
05 Nov 2024 //
FDA
Torrent`s Generics Deferasirox Receives Approval in US
05 Nov 2024 //
FDA
Dr. Reddys`s Generics Dasatinib Receives Tentative Approval in US
04 Nov 2024 //
FDA
Macleods`s Generics Lansoprazole Receives Approval in US
04 Nov 2024 //
FDA
Novartis`s Biologic Ilaris Receives Suppl Approval in US
01 Nov 2024 //
FDA
AstraZeneca`s Byetta Receives Approval in US
01 Nov 2024 //
FDA
Somerst`s Generics Dicyclomine HCl Receives Approval in US
01 Nov 2024 //
FDA
Sanofi`s Biologic Soliqua Receives Suppl Approval in US
01 Nov 2024 //
FDA
Cipla`s Generics Sodium Thiosulfate Receives Tentative Approval in US
01 Nov 2024 //
FDA
Sanofi`s Biologic Sarclisa Receives Suppl Approval in US
25 Oct 2024 //
FDA
Sandoz`s Biologic Wyost (Denosumab-bbdz) Receives Suppl Approval in US
24 Oct 2024 //
FDA
Sandoz`s Biologic Jubbonti (Denosumab-bbdz) Receives Suppl Approval in US
24 Oct 2024 //
FDA
Regeneron`s Biologic Inmazeb Receives Suppl Approval in US
24 Oct 2024 //
FDA
Novitium Pharma`s Generics Estradiol Receives Approval in US
23 Oct 2024 //
FDA
Osmotica Pharma`s Generics Carbamazepine Receives Approval in US
22 Oct 2024 //
FDA
Hetero Labs`s Generics Mycophenolate Mofetil Receives Approval in US
22 Oct 2024 //
FDA
